US20080041506A1 - Alloy and method of treating titanium aluminide - Google Patents

Alloy and method of treating titanium aluminide Download PDF

Info

Publication number
US20080041506A1
US20080041506A1 US11/889,917 US88991707A US2008041506A1 US 20080041506 A1 US20080041506 A1 US 20080041506A1 US 88991707 A US88991707 A US 88991707A US 2008041506 A1 US2008041506 A1 US 2008041506A1
Authority
US
United States
Prior art keywords
alloy
titanium aluminide
temperature
alpha
cooling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/889,917
Inventor
Aijun Huang
Michael Loretto
Xinhua Wu
Dawei Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rolls Royce PLC
Original Assignee
Rolls Royce PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolls Royce PLC filed Critical Rolls Royce PLC
Assigned to ROLLS-ROYCE PLC reassignment ROLLS-ROYCE PLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HU, DAWEI, HUANG, AIJUN, LORETTO, MICHAEL, WU, XINHUA
Publication of US20080041506A1 publication Critical patent/US20080041506A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/16—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of other metals or alloys based thereon
    • C22F1/18—High-melting or refractory metals or alloys based thereon
    • C22F1/183—High-melting or refractory metals or alloys based thereon of titanium or alloys based thereon
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C14/00—Alloys based on titanium
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C21/00—Alloys based on aluminium
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/04—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of aluminium or alloys based thereon
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04D—NON-POSITIVE-DISPLACEMENT PUMPS
    • F04D29/00—Details, component parts, or accessories
    • F04D29/002—Details, component parts, or accessories especially adapted for elastic fluid pumps

Definitions

  • the present invention relates to an alloy and a method of improving massive transformation in gamma titanium aluminide.
  • a problem with this heat-treatment is that the normal rapid cooling or quenching, of the titanium aluminide from above the alpha transus to ambient temperature induces quenching stresses in the titanium aluminide. The quenching stresses may result in cracking, particularly of castings. A further problem is that the heat-treatment is only suitable for relatively thin castings due to limiting cross-section.
  • Cracking during cooling or quenching from above the alpha transus temperature is related to both cooling rate and the dimensions of the titanium aluminide casting. Generally, cracking is promoted by relatively high cooling rates, by relatively large dimension castings and by large differences in cross section.
  • the cooling rate also affects the massive transformation of the gamma titanium aluminide. If the quench is too fast then the microstructure will remain as retained alpha phase, too slow and the alloy will precipitate gamma grains.
  • Such discontinuity within the grain is undesirable as it affects the properties of the alloy, giving areas of reduced ductility.
  • a method of enhancing massive transformation of a titanium aluminide alloy having a single alpha phase field by incorporating into the alloy up to 0.5 at % of oxygen scouring means which inhibits diffusion of oxygen within the alpha phase field to the grain boundary as the alloy is subjected to a temperature cycle which produces a massively transformed gamma microstructure.
  • oxygen scouring means is incorporated up to 0.2 at %.
  • the temperature cycle comprises the steps a) heating the titanium aluminide alloy to a temperature above the alpha transus temperature, b) maintaining the titanium aluminide alloy at a temperature above the alpha transus temperature for a predetermined time period, c) cooling the titanium aluminide alloy from the single alpha phase field to produce a massively transformed gamma microstructure.
  • the heat treatment may further comprise the step of d) heating the titanium aluminide to a temperature below the alpha transus temperature in the alpha and gamma phase field, e) maintaining the titanium aluminide at the temperature below the alpha transus temperature for a predetermined time period to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced, and f) cooling the titanium aluminide to ambient temperature.
  • the oxygen securing means is yttrium.
  • the alloy consists at least 43 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • Step c) may comprise cooling the titanium aluminide to ambient temperature.
  • the titanium aluminide may be cooled by gas cooling, oil cooling, fluidised bed cooling or salt cooling.
  • Step c) may comprise cooling the titanium aluminide at a cooling rate of 4° C.S ⁇ 1 to 150° C.S ⁇ 1 .
  • the titanium aluminide alloy is a cast titanium aluminide component.
  • the method may further comprise the step, of hot isostatic pressing the cast titanium aluminide component.
  • the titanium aluminide alloy provides a compressor or turbine blade or vane.
  • an alloy consisting of 43 at % to 50 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • the alloy consists of 45 to 46 at % aluminium, 7 to 9 at % niobium, 0.02 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • the niobium plus tantalum is less than or equal to 10 at %.
  • the titanium aluminide alloy may be a cast titanium aluminide component.
  • FIG. 1 is a graph of temperature versus time illustrating a method of heat-treating a titanium aluminide alloy according to the present invention.
  • FIG. 2 is a schematic view of the microstructure of a titanium aluminide alloy according to the present invention
  • FIG. 3 is a schematic view depicting O 2 diffusion to the grain boundary.
  • FIG. 4 is a schematic of gamma phase transformation with scoured oxygen.
  • FIG. 5 is a gamma titanium aluminide alloy gas turbine engine compressor blade according to the present invention.
  • a method of heat-treating a titanium aluminide alloy is described with reference to FIG. 1 .
  • the heat treatment process comprises heating the gamma titanium aluminide to a temperature T 1 above the alpha transus temperature T ⁇ .
  • the gamma titanium aluminide alloy is then maintained at a temperature T 1 above the alpha transus temperature T ⁇ in the single alpha phase field for a predetermined time period t 1 .
  • the gamma titanium aluminide is quenched, for example air cooled, or oil cooled, from the single alpha phase field at temperature T 1 to produce a massively transformed gamma microstructure.
  • the gamma titanium aluminide alloy is then heated to a temperature T 2 below the alpha transus temperature T ⁇ .
  • the gamma titanium aluminide alloy is maintained at the temperature T 2 in the alpha and gamma phase field for a predetermined time period t 2 to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced in the titanium aluminide alloy.
  • the gamma titanium aluminide is cooled, for example air cooled, or furnace cooled, to ambient temperature.
  • the diffusion has been found to occur even at low concentrations of around 500 to 1500 ppm dissolved oxygen, which means that even at overall low concentrations within the grain quite high concentrations at the grain boundary can be observed sufficient to inhibit massive transformation.
  • the quench rate is slower, for example to avoid cracking of the cast component, the relative oxygen diffusion is greater with more of the dissolved oxygen being given time to diffuse to the grain boundary. Consequently the overall inhibition of massive transformation may be greater.
  • a cast component is formed from an alloy having 45.5 at % aluminium, 8 at % niobium, 0.1 at % yttrium and the balance titanium plus incidental impurities.
  • the yttrium combines with dissolved oxygen at the casting solidification stage to form yttria.
  • the cast alloy is heat treated by a process comprising heating the titanium aluminide to a temperature T 1 above the alpha transus temperature T ⁇ .
  • the titanium aluminide alloy is maintained at the temperature T 1 in the single alpha phase field for a predetermined time period t 1 , up to 2 hours.
  • T 1 is about 20° C. to 30° C. above the alpha transus temperature T ⁇ , which is about 1300° C.
  • the titanium aluminide is quenched by, for example fluidised bed, salt bath or air cooling, from the single alpha phase field at temperature T 1 to a temperature T 2 .
  • the yttrium scours the oxygen as yttria within the grain and prevents it diffusing to the grain boundary during the quench process, which keeps the dissolved oxygen content at the grain boundary low and particularly below concentrations that inhibit massive transformation.
  • the quench rate can be slower as build-up of oxygen at the grain boundary is prevented. A more complete massive transformation is achieved and the risk or component cracking significantly reduced.
  • Temperature T 2 is preferably ambient, but may be a temperature in the range 900° C. to 1200° C. Following the cool or quench the titanium aluminide alloy is heated to a temperature of about 1250° C. to about 1290° C. for about 4 hours to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced in the titanium aluminide alloy.
  • the precipitated alpha plates have different orientations within the massively transformed microstructure which gives rise to a very fine duplex microstructure.
  • Such a microstructure is depicted schematically in FIG. 2 .
  • Differently orientated alpha plates precipitated in a massive gamma phase matrix effectively reduce the grain size of the gamma titanium aluminide alloy and these are produced by the massive gamma to alpha+gamma phase transformation.
  • the present invention is applicable generally to gamma titanium aluminide alloys having at least 43 at % aluminium, 0 to 9 at % niobium, 0 to 10% tantalum and 0.01 to 0.15 at % yttrium with the balance being titanium plus incidental impurities.
  • the gamma titanium aluminide alloy must have a single alpha phase field, the alloy must have a massive phase transformation normally requiring high aluminium concentration.
  • oxygen scouring materials e.g. hafnium may be used within the current alloy either in place of, or in combination with the yttrium.
  • Low quantities of the scouring medium are required to avoid a reduction in the qualities of the alloy.
  • higher quantities [above what level?] of the scouring material can cause the formation of large oxide particles which are detrimental to mechanical properties such as fatigue and ductility.
  • the advantages of the present invention are that the limitation of oxygen diffusion allows the quench to be performed at slower rate as less oxygen can migrate to the grain boundary and allows the alloy to be cast in both thick and thin sections.
  • Quench rate is generally faster at the surface of the component and slower within the body of the component. Thicker sections are enabled as within the body the oxygen migration to the grain boundary is reduced over the longer quench time.
  • the enabled slower cooling rate also allows the gamma titanium aluminide to be grain refined with reduced likelihood of cracking, distortion and potential scrap rates.
  • Casting is an economically competitive manufacturing route but its commercial use is dependent on grain refinement which can be achieved from the massive transformation that is applied by quenching current gamma titanium aluminide alloys. This is a problem for large components of variable cross section as cracking is likely to occur and the transformation may not extend to the centre of the section where the cooling rate is much smaller.
  • the invention allows the use of alloys that have a higher initial dissolved oxygen content than previously.
  • the invention opens the possibility of being able to reuse recycled material.
  • the advantage of this invention lies in the ease of application of the air cool and ageing process to give a strong, ductile material through a small addition to the alloy composition.
  • the ability to soak in the single alpha phase field with an unrestricted holding time allow this process to be carried out in normal heat treatment facilities and it also acts as a homogenisation treatment when applied to cast TiAl alloys.
  • the low cooling rate requirement in air lowers the possibility of cracking and distortion of the component.
  • the cast alloy may be hot isostatically pressed (HIP).
  • HIP hot isostatically pressed
  • the HIP process may occur before the alloy is heat treated, or more preferably it occurs at the same time as the alloy is aged after quenching. This is beneficial because it dispenses with the requirement for a separate HIP step.
  • the present invention is particularly suitable for gamma titanium aluminide gas turbine engine compressor blades as illustrated in FIG. 5 .
  • the compressor blade 10 comprises a root 12 , a shank 14 , a platform 16 and an aerofoil 18 .
  • the present invention is also suitable for gamma titanium aluminide gas turbine engine compressor vanes or other gamma titanium aluminide gas turbine engine components.
  • the present invention may also be suitable for gamma titanium aluminide components for other engines, machines or applications.

Abstract

A method of treating a titanium aluminide alloy having a single alpha phase field and being capable of producing a massively transformed gamma microstructure by subjecting the alloy to a temperature cycle that produces the massively transformed microstructure having a refined microstructure; the method being characterised in that oxygen securing means are provided within the alloy to prevent diffusion of oxygen to the grain boundary.

Description

  • The present invention relates to an alloy and a method of improving massive transformation in gamma titanium aluminide.
  • There is a requirement to refine the microstructure of a titanium aluminide alloy, in particular cast titanium aluminide alloy, which does not involve hot working.
  • Our published European patent application EP1378582A1 discloses a method of heat-treating a titanium aluminide alloy having a single alpha phase field and being capable of producing a massively transformed gamma microstructure. In that method of heat-treating the titanium aluminide alloy is heated to a temperature above the alpha transus temperature, is maintained above the alpha transus temperature in the single alpha phase field for a predetermined time period, is cooled from the single alpha phase field to ambient temperature to produce a massively transformed gamma microstructure, is heated to a temperature below the alpha transus temperature in the alpha and gamma phase field, is maintained at the temperature below the alpha transus temperature for a predetermined time period to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced and is then cooled to ambient temperature.
  • A problem with this heat-treatment is that the normal rapid cooling or quenching, of the titanium aluminide from above the alpha transus to ambient temperature induces quenching stresses in the titanium aluminide. The quenching stresses may result in cracking, particularly of castings. A further problem is that the heat-treatment is only suitable for relatively thin castings due to limiting cross-section.
  • Cracking during cooling or quenching from above the alpha transus temperature, is related to both cooling rate and the dimensions of the titanium aluminide casting. Generally, cracking is promoted by relatively high cooling rates, by relatively large dimension castings and by large differences in cross section.
  • However, the cooling rate also affects the massive transformation of the gamma titanium aluminide. If the quench is too fast then the microstructure will remain as retained alpha phase, too slow and the alloy will precipitate gamma grains.
  • It has now been found that with conventional massively transformed alloys there can be areas with little transformation at the grain boundary. This discovery is surprising as it is believed that the massive phase transformation starts at the grain boundary and grows into the centre of the grain.
  • Such discontinuity within the grain is undesirable as it affects the properties of the alloy, giving areas of reduced ductility.
  • It is an object of the present invention to seek to provide an improved alloy and an improved method of producing a massively transformed alloy of titanium aluminide.
  • It is a further object of the present invention to seek to provide an improved method of producing a massively transformed gamma titanium aluminide from an alloy containing greater quantities of dispersed oxygen.
  • According to a first aspect of the invention there is provided a method of enhancing massive transformation of a titanium aluminide alloy having a single alpha phase field by incorporating into the alloy up to 0.5 at % of oxygen scouring means which inhibits diffusion of oxygen within the alpha phase field to the grain boundary as the alloy is subjected to a temperature cycle which produces a massively transformed gamma microstructure.
  • Preferably the oxygen scouring means is incorporated up to 0.2 at %.
  • Preferably the temperature cycle comprises the steps a) heating the titanium aluminide alloy to a temperature above the alpha transus temperature, b) maintaining the titanium aluminide alloy at a temperature above the alpha transus temperature for a predetermined time period, c) cooling the titanium aluminide alloy from the single alpha phase field to produce a massively transformed gamma microstructure.
  • The heat treatment may further comprise the step of d) heating the titanium aluminide to a temperature below the alpha transus temperature in the alpha and gamma phase field, e) maintaining the titanium aluminide at the temperature below the alpha transus temperature for a predetermined time period to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced, and f) cooling the titanium aluminide to ambient temperature.
  • Preferably the oxygen securing means is yttrium. Preferably the alloy consists at least 43 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • Step c) may comprise cooling the titanium aluminide to ambient temperature. The titanium aluminide may be cooled by gas cooling, oil cooling, fluidised bed cooling or salt cooling.
  • Step c) may comprise cooling the titanium aluminide at a cooling rate of 4° C.S−1 to 150° C.S−1.
  • Preferably the titanium aluminide alloy is a cast titanium aluminide component.
  • The method may further comprise the step, of hot isostatic pressing the cast titanium aluminide component.
  • Preferably the titanium aluminide alloy provides a compressor or turbine blade or vane.
  • According to a second aspect of the invention there is provided an alloy consisting of 43 at % to 50 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • Preferably the alloy consists of 45 to 46 at % aluminium, 7 to 9 at % niobium, 0.02 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
  • Preferably the niobium plus tantalum is less than or equal to 10 at %.
  • The titanium aluminide alloy may be a cast titanium aluminide component.
  • The invention will now be described by way of example only with reference to the accompanying drawings in which:
  • FIG. 1 is a graph of temperature versus time illustrating a method of heat-treating a titanium aluminide alloy according to the present invention.
  • FIG. 2 is a schematic view of the microstructure of a titanium aluminide alloy according to the present invention
  • FIG. 3 is a schematic view depicting O2 diffusion to the grain boundary.
  • FIG. 4 is a schematic of gamma phase transformation with scoured oxygen.
  • FIG. 5 is a gamma titanium aluminide alloy gas turbine engine compressor blade according to the present invention.
  • A method of heat-treating a titanium aluminide alloy is described with reference to FIG. 1. The heat treatment process comprises heating the gamma titanium aluminide to a temperature T1 above the alpha transus temperature Tα. The gamma titanium aluminide alloy is then maintained at a temperature T1 above the alpha transus temperature Tα in the single alpha phase field for a predetermined time period t1. The gamma titanium aluminide is quenched, for example air cooled, or oil cooled, from the single alpha phase field at temperature T1 to produce a massively transformed gamma microstructure. The gamma titanium aluminide alloy is then heated to a temperature T2 below the alpha transus temperature Tα. The gamma titanium aluminide alloy is maintained at the temperature T2 in the alpha and gamma phase field for a predetermined time period t2 to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced in the titanium aluminide alloy. The gamma titanium aluminide is cooled, for example air cooled, or furnace cooled, to ambient temperature.
  • With the alloys described in EP1378582A1 it has been found that in some cases there can be areas with little transformation at the grain boundary—only inside the grain is transformed. This discovery was surprising as massive phase transformation normally starts as the grain boundary and precipitates to the centre of the grain.
  • It has now been found that within the grain dissolved oxygen diffuses to the grain boundary during the quench stage, rather than remaining dispersed within the grain, to provide concentrations at the boundary that are sufficiently high such that nucleation of the massive transform is prevented and consequently massive transformation throughout the grain is inhibited. Such a process is depicted schematically in FIG. 3.
  • The diffusion has been found to occur even at low concentrations of around 500 to 1500 ppm dissolved oxygen, which means that even at overall low concentrations within the grain quite high concentrations at the grain boundary can be observed sufficient to inhibit massive transformation. Where the quench rate is slower, for example to avoid cracking of the cast component, the relative oxygen diffusion is greater with more of the dissolved oxygen being given time to diffuse to the grain boundary. Consequently the overall inhibition of massive transformation may be greater.
  • In the present invention a cast component is formed from an alloy having 45.5 at % aluminium, 8 at % niobium, 0.1 at % yttrium and the balance titanium plus incidental impurities. The yttrium combines with dissolved oxygen at the casting solidification stage to form yttria.
  • The cast alloy is heat treated by a process comprising heating the titanium aluminide to a temperature T1 above the alpha transus temperature Tα. The titanium aluminide alloy is maintained at the temperature T1 in the single alpha phase field for a predetermined time period t1, up to 2 hours. T1 is about 20° C. to 30° C. above the alpha transus temperature Tα, which is about 1300° C. By holding at temperature T1 for a period t1 the cast titanium aluminide alloys are homogenised.
  • The titanium aluminide is quenched by, for example fluidised bed, salt bath or air cooling, from the single alpha phase field at temperature T1 to a temperature T2. As depicted in FIG. 4, the yttrium scours the oxygen as yttria within the grain and prevents it diffusing to the grain boundary during the quench process, which keeps the dissolved oxygen content at the grain boundary low and particularly below concentrations that inhibit massive transformation.
  • Since the oxygen is secured the quench rate can be slower as build-up of oxygen at the grain boundary is prevented. A more complete massive transformation is achieved and the risk or component cracking significantly reduced.
  • Temperature T2 is preferably ambient, but may be a temperature in the range 900° C. to 1200° C. Following the cool or quench the titanium aluminide alloy is heated to a temperature of about 1250° C. to about 1290° C. for about 4 hours to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced in the titanium aluminide alloy. The precipitated alpha plates have different orientations within the massively transformed microstructure which gives rise to a very fine duplex microstructure.
  • Such a microstructure is depicted schematically in FIG. 2. Differently orientated alpha plates precipitated in a massive gamma phase matrix effectively reduce the grain size of the gamma titanium aluminide alloy and these are produced by the massive gamma to alpha+gamma phase transformation.
  • The present invention is applicable generally to gamma titanium aluminide alloys having at least 43 at % aluminium, 0 to 9 at % niobium, 0 to 10% tantalum and 0.01 to 0.15 at % yttrium with the balance being titanium plus incidental impurities. The gamma titanium aluminide alloy must have a single alpha phase field, the alloy must have a massive phase transformation normally requiring high aluminium concentration.
  • Other oxygen scouring materials e.g. hafnium may be used within the current alloy either in place of, or in combination with the yttrium. Low quantities of the scouring medium are required to avoid a reduction in the qualities of the alloy. For example, higher quantities [above what level?] of the scouring material can cause the formation of large oxide particles which are detrimental to mechanical properties such as fatigue and ductility.
  • The advantages of the present invention are that the limitation of oxygen diffusion allows the quench to be performed at slower rate as less oxygen can migrate to the grain boundary and allows the alloy to be cast in both thick and thin sections. Quench rate is generally faster at the surface of the component and slower within the body of the component. Thicker sections are enabled as within the body the oxygen migration to the grain boundary is reduced over the longer quench time. The enabled slower cooling rate also allows the gamma titanium aluminide to be grain refined with reduced likelihood of cracking, distortion and potential scrap rates.
  • Casting is an economically competitive manufacturing route but its commercial use is dependent on grain refinement which can be achieved from the massive transformation that is applied by quenching current gamma titanium aluminide alloys. This is a problem for large components of variable cross section as cracking is likely to occur and the transformation may not extend to the centre of the section where the cooling rate is much smaller.
  • Additionally, by limiting the oxygen diffusion to the grain boundary more of the alloy will be massively transformed. Beneficially, the invention allows the use of alloys that have a higher initial dissolved oxygen content than previously. The invention opens the possibility of being able to reuse recycled material.
  • The advantage of this invention lies in the ease of application of the air cool and ageing process to give a strong, ductile material through a small addition to the alloy composition. The ability to soak in the single alpha phase field with an unrestricted holding time allow this process to be carried out in normal heat treatment facilities and it also acts as a homogenisation treatment when applied to cast TiAl alloys. The low cooling rate requirement in air lowers the possibility of cracking and distortion of the component.
  • It may be necessary to remove porosity from the cast titanium aluminide alloy component. In this case the cast alloy may be hot isostatically pressed (HIP). The HIP process may occur before the alloy is heat treated, or more preferably it occurs at the same time as the alloy is aged after quenching. This is beneficial because it dispenses with the requirement for a separate HIP step.
  • The present invention is particularly suitable for gamma titanium aluminide gas turbine engine compressor blades as illustrated in FIG. 5. The compressor blade 10 comprises a root 12, a shank 14, a platform 16 and an aerofoil 18. The present invention is also suitable for gamma titanium aluminide gas turbine engine compressor vanes or other gamma titanium aluminide gas turbine engine components. The present invention may also be suitable for gamma titanium aluminide components for other engines, machines or applications.

Claims (16)

1. A method of enhancing massive transformation of a titanium aluminide alloy having a single alpha phase field by incorporating up to 0.5 at % of oxygen scouring means into the alloy which inhibits diffusion of oxygen within the alpha phase field to the grain boundary as the alloy is subjected to a temperature cycle which produces a massively transformed gamma microstructure.
2. A method according to claim 1, wherein the oxygen scouring means is incorporated up to 0.2 at %.
3. A method according to claim 1, wherein the temperature cycle comprises the steps a) heating the titanium aluminide alloy to a temperature above the alpha transus temperature, b) maintaining the titanium aluminide alloy at a temperature above the alpha transus temperature for a predetermined time period, c) cooling the titanium aluminide alloy from the single alpha phase field to produce a massively transformed gamma microstructure.
4. A method according to claim 3, wherein the heat treatment further comprises the step of d) heating the titanium aluminide to a temperature below the alpha transus temperature in the alpha and gamma phase field, e) maintaining the titanium aluminide at the temperature below the alpha transus temperature for a predetermined time period to precipitate alpha plates in the massively transformed gamma microstructure such that a refined microstructure is produced, and f) cooling the titanium aluminide to ambient temperature.
5. A method according to claim 1, wherein the oxygen securing means is selected from the group comprising yttrium and hafnium.
6. A method according to claim 1, wherein the alloy consists at least 43 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
7. A method according to claim 1, wherein step c) comprises cooling the titanium aluminide to ambient temperature.
8. A method according to claim 1, wherein the titanium aluminide is cooled by gas cooling, oil cooling, fluidised bed cooling or salt cooling.
9. A method according to claim 1, wherein step c) comprises cooling the titanium aluminide at a cooling rate of 4° C.S−1 to 150° C.S−1.
10. A method as claimed in claim 1, wherein the titanium aluminide alloy is a cast titanium aluminide component.
11. A method as claimed in claim 10, wherein the method further comprises the step of hot isostatic pressing the cast titanium aluminide component.
12. A method as claimed in claim 1, wherein the titanium aluminide alloy provides a compressor blade or a compressor vane.
13. An alloy consisting of 43 to 50 at % aluminium, 0 to 9 at % niobium, 0 to 10 at % tantalum, 0.01 to 0.2 at % of yttrium and/or hafnium, the balance being titanium plus incidental impurities.
14. An alloy according to claim 13, consisting of 45 to 46 at % aluminium, 7 to 9 at % niobium, 0.02 to 0.15 at % yttrium, the balance being titanium plus incidental impurities.
15. An alloy according to claim 13, wherein the niobium plus tantalum is less than or equal to 10 at %.
16. An alloy claimed in claim 13, wherein the titanium aluminide alloy is a cast titanium aluminide component.
US11/889,917 2006-08-19 2007-08-17 Alloy and method of treating titanium aluminide Abandoned US20080041506A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0616566.6 2006-08-19
GBGB0616566.6A GB0616566D0 (en) 2006-08-19 2006-08-19 An alloy and method of treating titanium aluminide

Publications (1)

Publication Number Publication Date
US20080041506A1 true US20080041506A1 (en) 2008-02-21

Family

ID=37081319

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/889,917 Abandoned US20080041506A1 (en) 2006-08-19 2007-08-17 Alloy and method of treating titanium aluminide

Country Status (3)

Country Link
US (1) US20080041506A1 (en)
EP (1) EP1889939B1 (en)
GB (1) GB0616566D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007060587B4 (en) * 2007-12-13 2013-01-31 Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH titanium aluminide
CN113094946B (en) * 2021-03-23 2022-04-12 武汉大学 Phase field model localization self-adaptive algorithm for simulating material cracking

Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653841A (en) * 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3719564A (en) * 1971-05-10 1973-03-06 Philip Morris Inc Method of determining a reducible gas concentration and sensor therefor
US4008717A (en) * 1973-01-15 1977-02-22 The Johns Hopkins University System for continuous withdrawal and analysis of blood
US4016866A (en) * 1975-12-18 1977-04-12 General Electric Company Implantable electrochemical sensor
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4247297A (en) * 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4375399A (en) * 1978-09-08 1983-03-01 Radelkis Elektrokemiai Miszergyarto Szovetkezet Molecule selective sensor for industrial use and procedure for its preparation
US4384586A (en) * 1978-02-17 1983-05-24 Christiansen Torben F Method and apparatus for pH recording
US4427770A (en) * 1982-06-14 1984-01-24 Miles Laboratories, Inc. High glucose-determining analytical element
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4440175A (en) * 1981-08-10 1984-04-03 University Patents, Inc. Membrane electrode for non-ionic species
US4450842A (en) * 1980-04-25 1984-05-29 Cordis Corporation Solid state reference electrode
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4581336A (en) * 1982-04-26 1986-04-08 Uop Inc. Surface-modified electrodes
US4633878A (en) * 1983-04-18 1987-01-06 Guiseppe Bombardieri Device for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawal
US4637403A (en) * 1985-04-08 1987-01-20 Garid, Inc. Glucose medical monitoring system
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4654197A (en) * 1983-10-18 1987-03-31 Aktiebolaget Leo Cuvette for sampling and analysis
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4655885A (en) * 1985-01-11 1987-04-07 National Research Development Corporation Surface-modified electrode and its use in a bioelectrochemical process
US4717673A (en) * 1984-11-23 1988-01-05 Massachusetts Institute Of Technology Microelectrochemical devices
US4721601A (en) * 1984-11-23 1988-01-26 Massachusetts Institute Of Technology Molecule-based microelectronic devices
US4721677A (en) * 1985-09-18 1988-01-26 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4726378A (en) * 1986-04-11 1988-02-23 Minnesota Mining And Manufacturing Company Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus
US4726716A (en) * 1986-07-21 1988-02-23 Mcguire Thomas V Fastener for catheter
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4795707A (en) * 1984-11-27 1989-01-03 Hitachi, Ltd. Electrochemical sensor having three layer membrane containing immobilized enzymes
US4796634A (en) * 1985-08-09 1989-01-10 Lawrence Medical Systems, Inc. Methods and apparatus for monitoring cardiac output
US4805624A (en) * 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4813424A (en) * 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US4815469A (en) * 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
US4822337A (en) * 1987-06-22 1989-04-18 Stanley Newhouse Insulin delivery method and apparatus
US4830959A (en) * 1985-11-11 1989-05-16 Medisense, Inc. Electrochemical enzymic assay procedures
US4832797A (en) * 1985-11-28 1989-05-23 Imperial Chemical Industries Plc Enzyme electrode and membrane
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4894137A (en) * 1986-09-12 1990-01-16 Omron Tateisi Electronics Co. Enzyme electrode
US4897162A (en) * 1986-11-14 1990-01-30 The Cleveland Clinic Foundation Pulse voltammetry
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US4909908A (en) * 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
US4911794A (en) * 1986-06-20 1990-03-27 Molecular Devices Corporation Measuring with zero volume cell
US4917800A (en) * 1986-07-07 1990-04-17 Bend Research, Inc. Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers
US4919767A (en) * 1987-08-04 1990-04-24 Imperial Chemical Industries Plc Sensor and method for analyte determination
US4919141A (en) * 1987-01-03 1990-04-24 Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH Implantable electrochemical sensor
US4923586A (en) * 1987-03-31 1990-05-08 Daikin Industries, Ltd. Enzyme electrode unit
US4927516A (en) * 1986-06-27 1990-05-22 Terumo Kabushiki Kaisha Enzyme sensor
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US5001054A (en) * 1986-06-26 1991-03-19 Becton, Dickinson And Company Method for monitoring glucose
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5082786A (en) * 1987-11-26 1992-01-21 Nec Corporation Glucose sensor with gel-immobilized glucose oxidase and gluconolactonase
US5089112A (en) * 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US5095904A (en) * 1989-09-08 1992-03-17 Cochlear Pty. Ltd. Multi-peak speech procession
US5101814A (en) * 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5108564A (en) * 1988-03-15 1992-04-28 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
US5109850A (en) * 1990-02-09 1992-05-05 Massachusetts Institute Of Technology Automatic blood monitoring for medication delivery method and apparatus
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5198367A (en) * 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
US5202261A (en) * 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5205920A (en) * 1989-03-03 1993-04-27 Noboru Oyama Enzyme sensor and method of manufacturing the same
US5208154A (en) * 1991-04-08 1993-05-04 The United States Of America As Represented By The Department Of Energy Reversibly immobilized biological materials in monolayer films on electrodes
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US5284156A (en) * 1991-08-30 1994-02-08 M3 Systems, Inc. Automatic tissue sampling apparatus
US5286364A (en) * 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5288636A (en) * 1989-12-15 1994-02-22 Boehringer Mannheim Corporation Enzyme electrode system
US5293546A (en) * 1991-04-17 1994-03-08 Martin Marietta Corporation Oxide coated metal grid electrode structure in display devices
US5378628A (en) * 1991-02-21 1995-01-03 Asulab, S.A. Sensor for measuring the amount of a component in solution
US5387327A (en) * 1992-10-19 1995-02-07 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5395504A (en) * 1993-02-04 1995-03-07 Asulab S.A. Electrochemical measuring system with multizone sensors
US5400782A (en) * 1992-10-07 1995-03-28 Graphic Controls Corporation Integral medical electrode including a fusible conductive substrate
US5491474A (en) * 1991-05-22 1996-02-13 Polar Electro Oy Telemetric transmitter unit
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5496453A (en) * 1991-05-17 1996-03-05 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5596150A (en) * 1995-03-08 1997-01-21 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Capacitance probe for fluid flow and volume measurements
US5617851A (en) * 1992-10-14 1997-04-08 Endodermic Medical Technologies Company Ultrasonic transdermal system for withdrawing fluid from an organism and determining the concentration of a substance in the fluid
US5708247A (en) * 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
US5711297A (en) * 1993-12-29 1998-01-27 First Opinion Corporation Computerized medical advice system and method including meta function
US5711862A (en) * 1995-03-15 1998-01-27 Omron Corporation Portable biochemical measurement device using an enzyme sensor
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6368141B1 (en) * 1997-06-09 2002-04-09 Vanantwerp Nannette M. Insertion set for a transcutenous sensor with cable connector lock mechanism
US6368274B1 (en) * 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US20030078560A1 (en) * 2001-09-07 2003-04-24 Miller Michael E. Method and system for non-vascular sensor implantation
US20040002682A1 (en) * 1997-02-05 2004-01-01 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US20040003877A1 (en) * 2002-07-05 2004-01-08 Dawei Hu Method of heat treating titanium aluminide
US6695860B1 (en) * 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
US20040045644A1 (en) * 2000-05-17 2004-03-11 Volker Guther T-tial alloy-based component comprising areas having a graduated structure
US20040064133A1 (en) * 2002-09-27 2004-04-01 Medtronic-Minimed Implantable sensor method and system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2860064B2 (en) * 1994-10-17 1999-02-24 株式会社神戸製鋼所 Method for producing Ti-Al alloy target material
GB0319061D0 (en) * 2003-08-14 2003-09-17 Rolls Royce Plc A method of heat treating titanium aluminide
GB0601662D0 (en) * 2006-01-27 2006-03-08 Rolls Royce Plc A method for heat treating titanium aluminide

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653841A (en) * 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3719564A (en) * 1971-05-10 1973-03-06 Philip Morris Inc Method of determining a reducible gas concentration and sensor therefor
US4008717A (en) * 1973-01-15 1977-02-22 The Johns Hopkins University System for continuous withdrawal and analysis of blood
US4016866A (en) * 1975-12-18 1977-04-12 General Electric Company Implantable electrochemical sensor
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4384586A (en) * 1978-02-17 1983-05-24 Christiansen Torben F Method and apparatus for pH recording
US4375399A (en) * 1978-09-08 1983-03-01 Radelkis Elektrokemiai Miszergyarto Szovetkezet Molecule selective sensor for industrial use and procedure for its preparation
US4247297A (en) * 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4450842A (en) * 1980-04-25 1984-05-29 Cordis Corporation Solid state reference electrode
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4440175A (en) * 1981-08-10 1984-04-03 University Patents, Inc. Membrane electrode for non-ionic species
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4581336A (en) * 1982-04-26 1986-04-08 Uop Inc. Surface-modified electrodes
US4427770A (en) * 1982-06-14 1984-01-24 Miles Laboratories, Inc. High glucose-determining analytical element
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4633878A (en) * 1983-04-18 1987-01-06 Guiseppe Bombardieri Device for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawal
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4654197A (en) * 1983-10-18 1987-03-31 Aktiebolaget Leo Cuvette for sampling and analysis
US4820399A (en) * 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
US4717673A (en) * 1984-11-23 1988-01-05 Massachusetts Institute Of Technology Microelectrochemical devices
US4721601A (en) * 1984-11-23 1988-01-26 Massachusetts Institute Of Technology Molecule-based microelectronic devices
US4795707A (en) * 1984-11-27 1989-01-03 Hitachi, Ltd. Electrochemical sensor having three layer membrane containing immobilized enzymes
US4655885A (en) * 1985-01-11 1987-04-07 National Research Development Corporation Surface-modified electrode and its use in a bioelectrochemical process
US4637403A (en) * 1985-04-08 1987-01-20 Garid, Inc. Glucose medical monitoring system
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US4796634A (en) * 1985-08-09 1989-01-10 Lawrence Medical Systems, Inc. Methods and apparatus for monitoring cardiac output
US4805624A (en) * 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4721677A (en) * 1985-09-18 1988-01-26 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4830959A (en) * 1985-11-11 1989-05-16 Medisense, Inc. Electrochemical enzymic assay procedures
US4832797A (en) * 1985-11-28 1989-05-23 Imperial Chemical Industries Plc Enzyme electrode and membrane
US4726378A (en) * 1986-04-11 1988-02-23 Minnesota Mining And Manufacturing Company Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4909908A (en) * 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4911794A (en) * 1986-06-20 1990-03-27 Molecular Devices Corporation Measuring with zero volume cell
US5001054A (en) * 1986-06-26 1991-03-19 Becton, Dickinson And Company Method for monitoring glucose
US4927516A (en) * 1986-06-27 1990-05-22 Terumo Kabushiki Kaisha Enzyme sensor
US4917800A (en) * 1986-07-07 1990-04-17 Bend Research, Inc. Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers
US4726716A (en) * 1986-07-21 1988-02-23 Mcguire Thomas V Fastener for catheter
US4894137A (en) * 1986-09-12 1990-01-16 Omron Tateisi Electronics Co. Enzyme electrode
US4897162A (en) * 1986-11-14 1990-01-30 The Cleveland Clinic Foundation Pulse voltammetry
US4919141A (en) * 1987-01-03 1990-04-24 Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH Implantable electrochemical sensor
US4923586A (en) * 1987-03-31 1990-05-08 Daikin Industries, Ltd. Enzyme electrode unit
US5286364A (en) * 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US4822337A (en) * 1987-06-22 1989-04-18 Stanley Newhouse Insulin delivery method and apparatus
US4919767A (en) * 1987-08-04 1990-04-24 Imperial Chemical Industries Plc Sensor and method for analyte determination
US4815469A (en) * 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
US5082786A (en) * 1987-11-26 1992-01-21 Nec Corporation Glucose sensor with gel-immobilized glucose oxidase and gluconolactonase
US4813424A (en) * 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US5108564A (en) * 1988-03-15 1992-04-28 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
US5205920A (en) * 1989-03-03 1993-04-27 Noboru Oyama Enzyme sensor and method of manufacturing the same
US5089112A (en) * 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US5198367A (en) * 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
US4986271A (en) * 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US5101814A (en) * 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5095904A (en) * 1989-09-08 1992-03-17 Cochlear Pty. Ltd. Multi-peak speech procession
US5082550A (en) * 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5288636A (en) * 1989-12-15 1994-02-22 Boehringer Mannheim Corporation Enzyme electrode system
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5109850A (en) * 1990-02-09 1992-05-05 Massachusetts Institute Of Technology Automatic blood monitoring for medication delivery method and apparatus
US5202261A (en) * 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5378628A (en) * 1991-02-21 1995-01-03 Asulab, S.A. Sensor for measuring the amount of a component in solution
US5208154A (en) * 1991-04-08 1993-05-04 The United States Of America As Represented By The Department Of Energy Reversibly immobilized biological materials in monolayer films on electrodes
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5293546A (en) * 1991-04-17 1994-03-08 Martin Marietta Corporation Oxide coated metal grid electrode structure in display devices
US5496453A (en) * 1991-05-17 1996-03-05 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5491474A (en) * 1991-05-22 1996-02-13 Polar Electro Oy Telemetric transmitter unit
US5284156A (en) * 1991-08-30 1994-02-08 M3 Systems, Inc. Automatic tissue sampling apparatus
US5400782A (en) * 1992-10-07 1995-03-28 Graphic Controls Corporation Integral medical electrode including a fusible conductive substrate
US5617851A (en) * 1992-10-14 1997-04-08 Endodermic Medical Technologies Company Ultrasonic transdermal system for withdrawing fluid from an organism and determining the concentration of a substance in the fluid
US5387327A (en) * 1992-10-19 1995-02-07 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5395504A (en) * 1993-02-04 1995-03-07 Asulab S.A. Electrochemical measuring system with multizone sensors
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5711297A (en) * 1993-12-29 1998-01-27 First Opinion Corporation Computerized medical advice system and method including meta function
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5596150A (en) * 1995-03-08 1997-01-21 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Capacitance probe for fluid flow and volume measurements
US5711862A (en) * 1995-03-15 1998-01-27 Omron Corporation Portable biochemical measurement device using an enzyme sensor
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5711861A (en) * 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
US5708247A (en) * 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
US20040002682A1 (en) * 1997-02-05 2004-01-01 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6368141B1 (en) * 1997-06-09 2002-04-09 Vanantwerp Nannette M. Insertion set for a transcutenous sensor with cable connector lock mechanism
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6368274B1 (en) * 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US20040045644A1 (en) * 2000-05-17 2004-03-11 Volker Guther T-tial alloy-based component comprising areas having a graduated structure
US6695860B1 (en) * 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
US20030078560A1 (en) * 2001-09-07 2003-04-24 Miller Michael E. Method and system for non-vascular sensor implantation
US20040003877A1 (en) * 2002-07-05 2004-01-08 Dawei Hu Method of heat treating titanium aluminide
US20040064133A1 (en) * 2002-09-27 2004-04-01 Medtronic-Minimed Implantable sensor method and system

Also Published As

Publication number Publication date
GB0616566D0 (en) 2006-09-27
EP1889939A3 (en) 2008-10-29
EP1889939A2 (en) 2008-02-20
EP1889939B1 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
CA1244327A (en) Method for heat treating cast titanium articles to improve their mechanical properties
US7909947B2 (en) High strength L12 aluminum alloys
EP2112243B1 (en) High strength L12 aluminium alloys
EP2110453B1 (en) L12 Aluminium alloys
EP2112244A1 (en) High strength L12 aluminium alloys
JPH111737A (en) Heat treated type 7000 series aluminum alloy with excellent corrosion resistance and high strength, and its production
CN109628867B (en) Heat treatment method for obtaining peritectic casting TiAl alloy near lamellar structure
EP1061149B1 (en) Ti-Al-(Mo,V,Si,Fe) alloys and method of their manufacture
US7704339B2 (en) Method of heat treating titanium aluminide
CN108330419A (en) A kind of thermal deformation of Al-Mg-Mn-Er-Zr sheet alloys and its stabilization process
JP4035664B2 (en) Simple manufacturing method and apparatus for heat-treatable aluminum alloy castings
JPH0762222B2 (en) Method for manufacturing improved aluminum alloy sheet material
Fu et al. Enhancing mechanical properties of dual-phase Al0. 5CoCrFeNiSi0. 25 high entropy alloy via thermomechanical treatment
EP1889939B1 (en) An alloy and method of treating titanium aluminide
US5882446A (en) Heat treatment process for material bodies made of nickel base superalloys
US20190249283A1 (en) Heat treatment of aluminum alloys containing silicon and scandium
EP1378582B1 (en) A method of heat treating titanium aluminide
EP1038982A1 (en) Single crystal superalloy articles with reduced grain recrystallization
US20050081967A1 (en) Method of heat treating titanium aluminide
US20060225818A1 (en) Process for casting a beta-titanium alloy
JPH09227972A (en) Titanium-aluminium intermetallic compound base alloy material having superplasticity and its production
JPS62202061A (en) Manufacture of aluminum alloy material having fine grain
CN116815081A (en) Aluminum alloy heat treatment process for integral caliper casting
CN116262964A (en) Refining method of carbide in cast TiAl alloy
JP2001131723A (en) Method for improving ductility of cast material of titanium alloy

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROLLS-ROYCE PLC, ENGLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUANG, AIJUN;LORETTO, MICHAEL;WU, XINHUA;AND OTHERS;REEL/FRAME:019766/0222

Effective date: 20070716

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION